Prosecution Insights
Prosecution Insights
39 pending office actions • 18 art units • 32 examiners • 0 of 39 (0%) have an AI response strategy ready • 48 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 15 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 15 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (8%) |
| §103 only | 8 (21%) |
| §112 only | 12 (31%) |
| Double-patenting only | 3 (8%) |
| Double-patenting + other | 5 (13%) |
| Multi-statute (no §101) | 8 (21%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MIDDLETON, DANAYA L | 3 | 46.1% | +54.1% |
| SANG, HONG | 3 | 54.7% | +62.6% |
| HABTE, KAHSAY | 2 | 85.0% | +7.4% |
| BEANE, RANDALL L | 2 | 32.8% | +36.6% |
| PATTERSON, SARAH COOPER | 2 | 58.3% | +56.5% |
| GEMBEH, SHIRLEY V | 1 | 63.1% | +33.8% |
| KIEFER, DALTON EDWARD | 1 | — | — |
| CHEN, PO-CHIH | 1 | 74.3% | +14.4% |
| LANDSMAN, ROBERT S | 1 | 81.3% | +13.3% |
| WILLIS, DOUGLAS M | 1 | 82.4% | +19.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18726155 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING NRF2 ACTIVATION EFFECT | HABTE, KAHSAY | — |
| 18579949 | METHOD FOR PRODUCING ARYLAMIDE DERIVATIVE | HABTE, KAHSAY | — |
| 18289627 | ANTI-DDR2 ANTIBODIES AND USES THEREOF | LANDSMAN, ROBERT S | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17716467 | ANTIGEN-BINDING MOLECULE FOR PROMOTING CLEARANCE FROM PLASMA OF ANTIGEN COMPRISING SUGAR CHAIN RECEPTOR-BINDING DOMAIN | LI, RUIXIANG | 73d overdue |
| 18266665 | METHOD FOR MEASURING RELATIVE fu RATIO BY DYNAMIC ANALYSIS | NGUYEN, NAM P | 44d overdue |
| 15734755 | ANTIGEN-BINDING MOLECULE SHOWING CHANGED HALF-LIFE IN CYTOPLASM | CHASE, CAROL ANN | 31d overdue |
| 17926673 | IMPROVED GRANZYME B VARIANT | PATTERSON, SARAH COOPER | 11d overdue |
| 18458292 | THERAPEUTIC AGENT FOR CANCER OF PATIENT WITH DECREASE IN RB1 FUNCTION USING MYT1 INHIBITOR AND CHEMOTHERAPEUTIC AGENT IN COMBINATION, AND TREATMENT METHOD THEREOF | WILLIS, DOUGLAS M | 9d overdue |
| 17766280 | INHIBITOR OF CELL PROLIFERATION IN OBINUTUZUMAB RESISTANT CD20-POSITIVE CANCER, AND MEDICINAL COMPOSITION, MEDICINE, PRODUCTION, METHOD FOR INHIBITING CELL PROLIFERATION, THERAPEUTIC METHOD, TYPE II ANTI-CD20 ANTIBODY, COMPOUNDS, COMBINATION OF SAME, ENHANCER AND INDUCER, EACH RELATING THERETO | SANG, HONG | 29d |
| 18270793 | METHOD FOR ALKYLATING ACIDIC FUNCTIONAL GROUP | BAHTA, MEDHANIT W | — |
| 18268399 | MEDICINE PRODUCTION METHOD INCLUDING STEP OF FREEZE-DRYING WITH MIXED SOLVENT | BEANE, RANDALL L | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17144342 | ANTIGEN-BINDING MOLECULE FOR ELIMINATING AGGREGATED ANTIGENS | SANG, HONG | 53d overdue |
| 17926673 | IMPROVED GRANZYME B VARIANT | PATTERSON, SARAH COOPER | 11d overdue |
| 18458292 | THERAPEUTIC AGENT FOR CANCER OF PATIENT WITH DECREASE IN RB1 FUNCTION USING MYT1 INHIBITOR AND CHEMOTHERAPEUTIC AGENT IN COMBINATION, AND TREATMENT METHOD THEREOF | WILLIS, DOUGLAS M | 9d overdue |
| 17766280 | INHIBITOR OF CELL PROLIFERATION IN OBINUTUZUMAB RESISTANT CD20-POSITIVE CANCER, AND MEDICINAL COMPOSITION, MEDICINE, PRODUCTION, METHOD FOR INHIBITING CELL PROLIFERATION, THERAPEUTIC METHOD, TYPE II ANTI-CD20 ANTIBODY, COMPOUNDS, COMBINATION OF SAME, ENHANCER AND INDUCER, EACH RELATING THERETO | SANG, HONG | 29d |
| 18827277 | AMORPHOUS FORM OF TETRACYCLIC COMPOUND | GEMBEH, SHIRLEY V | — |
| 18580385 | PROTEASE-MEDIATED TARGET SPECIFIC CYTOKINE DELIVERY USING FUSION POLYPEPTIDE | MIDDLETON, DANAYA L | — |
| 18535310 | CYTOTOXICITY-INDUCING THERAPEUTIC AGENT | SANG, HONG | — |
| 18567432 | METHOD FOR PRODUCING DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE | CHEN, PO-CHIH | — |
| Art Unit | Apps |
|---|---|
| 1654 | 4 |
| 1641 | 4 |
| 1643 | 4 |
| 1624 | 3 |
| 1674 | 3 |
| 1675 | 3 |
| 1646 | 3 |
| 1658 | 2 |
| 1652 | 1 |
| 1621 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18827277 | AMORPHOUS FORM OF TETRACYCLIC COMPOUND | GEMBEH, SHIRLEY V | — | §103DP | Non-Final OA | — | Pending | Sep 06, 2024 |
| 18726155 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING NRF2 ACTIVATION EFFECT | HABTE, KAHSAY | 1624 | DP | Non-Final OA | — | Pending | Jul 02, 2024 |
| 18724369 | POLYPEPTIDE AND METHOD FOR PRODUCING AMINO ACID USING SAME | KIEFER, DALTON EDWARD | 1652 | §112 | Non-Final OA | — | Pending | Jun 26, 2024 |
| 18580385 | PROTEASE-MEDIATED TARGET SPECIFIC CYTOKINE DELIVERY USING FUSION POLYPEPTIDE | MIDDLETON, DANAYA L | — | §102§112DP | Non-Final OA | — | Pending | Jan 18, 2024 |
| 18579949 | METHOD FOR PRODUCING ARYLAMIDE DERIVATIVE | HABTE, KAHSAY | 1624 | §112 | Non-Final OA | — | Pending | Jan 17, 2024 |
| 18535310 | CYTOTOXICITY-INDUCING THERAPEUTIC AGENT | SANG, HONG | — | §103 | Non-Final OA | — | Pending | Dec 11, 2023 |
| 18567432 | METHOD FOR PRODUCING DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE | CHEN, PO-CHIH | 1621 | §112 | Non-Final OA | — | Pending | Dec 06, 2023 |
| 18289627 | ANTI-DDR2 ANTIBODIES AND USES THEREOF | LANDSMAN, ROBERT S | 1647 | §103 | Non-Final OA | — | Pending | Nov 06, 2023 |
| 18458292 | THERAPEUTIC AGENT FOR CANCER OF PATIENT WITH DECREASE IN RB1 FUNCTION USING MYT1 INHIBITOR AND CHEMOTHERAPEUTIC AGENT IN COMBINATION, AND TREATMENT METHOD THEREOF | WILLIS, DOUGLAS M | 1624 | §103§112 | Non-Final OA | 9d overdue | Pending | Aug 30, 2023 |
| 18270793 | METHOD FOR ALKYLATING ACIDIC FUNCTIONAL GROUP | BAHTA, MEDHANIT W | 1692 | §102§103 | Non-Final OA | — | Pending | Jul 03, 2023 |
| 18268737 | METHOD FOR PRODUCING PEPTIDE COMPOUND CONTAINING N-SUBSTITUTED-AMINO ACID RESIDUE | BOWLES, DAVID PAUL | 1654 | §102§103§112DP | Non-Final OA | — | Pending | Jun 21, 2023 |
| 18268399 | MEDICINE PRODUCTION METHOD INCLUDING STEP OF FREEZE-DRYING WITH MIXED SOLVENT | BEANE, RANDALL L | 1654 | §102§103§112 | Non-Final OA | — | Pending | Jun 20, 2023 |
| 18268470 | METHOD FOR SCREENING FOR CANDIDATE MOLECULE CAPABLE OF FORMING COMPLEX IN CONJUNCTION WITH PLURALITY OF TARGET MOLECULES | PHAM, KHAI QUYNH TIEN | 1684 | §103 | Final Rejection | — | Pending | Jun 20, 2023 |
| 18266665 | METHOD FOR MEASURING RELATIVE fu RATIO BY DYNAMIC ANALYSIS | NGUYEN, NAM P | 1678 | §102§103 | Final Rejection | 44d overdue | Pending | Jun 12, 2023 |
| 18034424 | PEPTIDE SYNTHESIS METHOD FOR SUPPRESSING DEFECT CAUSED BY DIKETOPIPERAZINE FORMATION | BEANE, RANDALL L | 1654 | §102§103§112DPOther | Non-Final OA | — | Pending | Apr 28, 2023 |
| 18250507 | SYRINGE | IGEL JR, MARK ALAN | 3783 | §103 | Final Rejection | — | Pending | Apr 25, 2023 |
| 18298743 | METHOD FOR ALTERING PLASMA RETENTION AND IMMUNOGENICITY OF ANTIGEN-BINDING MOLECULE | HUYNH, PHUONG N | 1641 | §112 | Non-Final OA | — | Pending | Apr 11, 2023 |
| 18023038 | HETERODIMER FC POLYPEPTIDE | MIDDLETON, DANAYA L | 1674 | §101§102§112DP | Final Rejection | — | Pending | Feb 24, 2023 |
| 18022342 | HETERODIMER FC POLYPEPTIDE | MIDDLETON, DANAYA L | 1674 | DP | Final Rejection | — | Pending | Feb 21, 2023 |
| 18018460 | METHOD FOR MEASURING PHARMACOKINETICS OF AGENT LABELED WITH NON-RADIOACTIVE SUBSTANCE | XU, XIAOYUN | 1797 | §103 | Final Rejection | — | Pending | Jan 27, 2023 |
| 17928759 | EFFICIENT PEPTIDE CONDENSATION METHOD FOR DIFFICULT SEQUENCES | NIEBAUER, RONALD T | 1658 | §103§112 | Final Rejection | — | Pending | Nov 30, 2022 |
| 17992032 | METHOD FOR SEARCHING AND SCREENING FOR TARGET OF ANTI-CANCER AGENT USING NON-HUMAN ANIMAL MODEL HAVING NOG ESTABLISHED CANCER CELL LINE TRANSPLANTED THEREIN | BEHARRY, ZANNA MARIA | 1632 | §103 | Non-Final OA | 91d overdue | Pending | Nov 22, 2022 |
| 17926673 | IMPROVED GRANZYME B VARIANT | PATTERSON, SARAH COOPER | 1675 | §101§102§103§112 | Non-Final OA | 11d overdue | Pending | Nov 21, 2022 |
| 17914432 | METHOD FOR PRODUCING MULTISPECIFIC ANTIGEN-BINDING MOLECULES | BRISTOL, LYNN ANNE | 1643 | §112 | Non-Final OA | 9d overdue | Pending | Sep 26, 2022 |
| 17798686 | ANTI-CD137 ANTIGEN-BINDING MOLECULE FOR USE IN CANCER TREATMENT | DONOGHUE, BRITTNEY ERIN | 1675 | §103§112DP | Final Rejection | — | Pending | Aug 10, 2022 |
| 17797540 | METHODS FOR PRODUCING AND/OR ENRICHING RECOMBINANT ANTIGEN-BINDING MOLECULES | ROONEY, NORA MAUREEN | 1641 | §112 | Final Rejection | 28d overdue | Pending | Aug 04, 2022 |
| 17788506 | METHOD FOR SYNTHESIZING PEPTIDE COMPOUND | REYNOLDS, FRED H | 1658 | §103 | Final Rejection | 44d overdue | Pending | Jun 23, 2022 |
| 17716467 | ANTIGEN-BINDING MOLECULE FOR PROMOTING CLEARANCE FROM PLASMA OF ANTIGEN COMPRISING SUGAR CHAIN RECEPTOR-BINDING DOMAIN | LI, RUIXIANG | 1674 | §101§102§103§112 | Non-Final OA | 73d overdue | Pending | Apr 08, 2022 |
| 17766280 | INHIBITOR OF CELL PROLIFERATION IN OBINUTUZUMAB RESISTANT CD20-POSITIVE CANCER, AND MEDICINAL COMPOSITION, MEDICINE, PRODUCTION, METHOD FOR INHIBITING CELL PROLIFERATION, THERAPEUTIC METHOD, TYPE II ANTI-CD20 ANTIBODY, COMPOUNDS, COMBINATION OF SAME, ENHANCER AND INDUCER, EACH RELATING THERETO | SANG, HONG | 1646 | §102§103§112 | Final Rejection | 29d | Pending | Apr 04, 2022 |
| 17587465 | MOLECULE SPECIFICALLY ACTING IN A TISSUE WHERE A CELL DEATH IS BEING OBSERVED | PATTERSON, SARAH COOPER | 1675 | §112 | Final Rejection | — | Pending | Jan 28, 2022 |
| 17625868 | ANTI-MUTATION TYPE FGFR3 ANTIBODY AND USE THEREFOR | CUNNINGCHEN, KATHLEEN MARY | 1600 | §112 | Non-Final OA | — | Pending | Jan 10, 2022 |
| 17621746 | ANTIGEN BINDING MOLECULES THAT BIND PDGF-B AND PDGF-D AND USES THEREOF | HOPKINS, SAMANTHA LAKE | 1641 | §103 | Non-Final OA | 62d | Pending | Dec 22, 2021 |
| 17438993 | ANTIGEN-BINDING MOLECULE CONTAINING ANTIGEN-BINDING DOMAIN OF WHICH BINDING ACTIVITY TO ANTIGEN IS CHANGED DEPENDING ON MTA, AND LIBRARY FOR OBTAINING SAID ANTIGEN-BINDING DOMAIN | SKOKO III, JOHN JOSEPH | 1643 | §112 | Non-Final OA | 114d overdue | Pending | Sep 14, 2021 |
| 17437448 | ANTI-IL-6 RECEPTOR ANTIBODY-CONTAINING INHIBITOR FOR INHIBITING DETERIORATION OF BBB FUNCTION | DAHLE, CHUN WU | 1641 | §103§112 | Non-Final OA | — | Pending | Sep 09, 2021 |
| 17290439 | HER2 S310F SPECIFIC ANTIGEN-BINDING MOLECULES | FAUST, AMBER KATHLEEN | 1643 | §112 | Final Rejection | 29d overdue | Pending | Apr 30, 2021 |
| 17144342 | ANTIGEN-BINDING MOLECULE FOR ELIMINATING AGGREGATED ANTIGENS | SANG, HONG | 1646 | §112 | Final Rejection | 53d overdue | Pending | Jan 08, 2021 |
| 15734755 | ANTIGEN-BINDING MOLECULE SHOWING CHANGED HALF-LIFE IN CYTOPLASM | CHASE, CAROL ANN | 1646 | §103§112 | Final Rejection | 31d overdue | Pending | Dec 03, 2020 |
| 17058896 | LIGAND-BINDING MOLECULE CONTAINING SINGLE DOMAIN ANTIBODY | EDGINGTONGIORDANO, FRANCESCA | 1643 | DP | Final Rejection | 38d overdue | Pending | Nov 25, 2020 |
| 16081522 | PRODUCTION METHOD FOR NONCYCLIC PEPTIDE-NUCLEIC ACID COMPLEX HAVING, AT N-TERMINAL, AMINO ACID WITH THIOL GROUP NEAR AMINO GROUP, LIBRARY THEREOF, AND CYCLIC PEPTIDE-NUCLEIC ACID COMPLEX LIBRARY DERIVED FROM SAME | AUDET, MAURY A | 1654 | §112 | Final Rejection | — | Pending | Jul 08, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial